Mimedx (MDXG) Operating Expenses (2011 - 2026)

Mimedx (MDXG) has 16 years of Operating Expenses data on file, last reported at $57.4 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 9.36% year-over-year to $57.4 million; the trailing twelve-month figure through Mar 2026 stood at $160.4 million (down 20.21% YoY), and the FY2025 full-year result was $71.6 million, down 69.84% from the prior year.
• Operating Expenses climbed to $57.4 million in Q1 2026, from $16.6 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $67.5 million in Q2 2025 to a low of -$106.1 million in Q4 2022.
• A 5-year average of $42.2 million and a median of $56.8 million in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses sank 327.15% in 2022 and surged 304.21% in 2025, its largest moves.
• Tracing MDXG's Operating Expenses over 5 years: stood at -$106.1 million in 2022, then surged by 153.51% to $56.8 million in 2023, then advanced by 13.79% to $64.6 million in 2024, then slumped by 74.31% to $16.6 million in 2025, then soared by 245.59% to $57.4 million in 2026.
• Business Quant data shows MDXG's Operating Expenses at $57.4 million in Q1 2026, $16.6 million in Q4 2025, and $19.0 million in Q3 2025.